Thus, our present study identified the ARID3A‐ATP1A2 axis as a novel pathway involved in AAA regulation, which not only provides new insights into the pathogenesis of AAA but also promotes the development of AAA diagnostic and treatment approaches. This evidence concerns the gene ARID3A and triple-A syndrome.